Biography and Research Information
OverviewAI-generated summary
Mitchell Rotenberry's research focuses on understanding and mitigating the adverse effects of radiation therapy, specifically intestinal toxicity. His recent publication, "Geranylgeranyl Transferase Inhibitors Mitigate Intestinal Radiation Toxicity," published in 2025, investigates potential therapeutic strategies. Rotenberry collaborates with researchers at the University of Arkansas for Medical Sciences, including Rupak Pathak, Ruofei Du, Kathleen E. McGinness, and Enoch K. Larrey, with whom he has co-authored publications. Rotenberry's scholarly activity indicates recent engagement in the field, with one publication to his name.
Metrics
- Publications: 1
Selected Publications
-
Geranylgeranyl Transferase Inhibitors Mitigate Intestinal Radiation Toxicity (2025)
Collaboration Network
Top Collaborators
- Geranylgeranyl Transferase Inhibitors Mitigate Intestinal Radiation Toxicity
- Geranylgeranyl Transferase Inhibitors Mitigate Intestinal Radiation Toxicity
- Geranylgeranyl Transferase Inhibitors Mitigate Intestinal Radiation Toxicity
- Geranylgeranyl Transferase Inhibitors Mitigate Intestinal Radiation Toxicity
- Geranylgeranyl Transferase Inhibitors Mitigate Intestinal Radiation Toxicity
- Geranylgeranyl Transferase Inhibitors Mitigate Intestinal Radiation Toxicity
- Geranylgeranyl Transferase Inhibitors Mitigate Intestinal Radiation Toxicity
Similar Researchers
Based on overlapping research topics